Research Article: Phase I, Single-Dose Study to Assess the Pharmacokinetics and Safety of Suramin in Healthy Chinese Volunteers
Introduction:
Suramin is a drug that has been used to treat both children and adults with African sleeping sickness and river blindness for over a century. It has also been shown to inhibit the replication of a variety of viruses, including enteroviruses, Zika virus, Chikungunya, Ebola viruses, and SARS-CoV-. – Suramin’s viral inhibition mechanisms are diverse, including inhibition of viral attachment, entry, and release from host cells, which is accomplished in part through interactions with viral capsid proteins. – , – Until…
Read more